Evaluation of H3K27me3 Expression as a Marker of EZH2 Activation in SMARCA4/SMARCA2-Deficient Tumors and Candidate Biomarker for Trials of EZH2 Inhibitors

被引：0
|
作者：
Kezlarian, Brie [1 ]
Montecalvo, Joseph [2 ]
Sauter, Jennifer [1 ]
Travis, William [1 ]
Gounder, Mrinal [1 ]
Rudin, Charles [1 ]
Ladanyi, Marc [1 ]
Namakydoust, Azadeh [3 ]
Rekhtman, Natasha [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Suny Downstate Med Ctr, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, Middletown, NJ USA
来源：
MODERN PATHOLOGY | 2019年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1844
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Ezh2 mediated H3K27me3 activity facilitates somatic transition during human pluripotent reprogramming
    Radhika Arasala Rao
    Narendra Dhele
    Sabna Cheemadan
    Alhad Ketkar
    Giridhara R. Jayandharan
    Dasaradhi Palakodeti
    Shravanti Rampalli
    Scientific Reports, 5
  • [42] Ezh2 mediated H3K27me3 activity facilitates somatic transition during human pluripotent reprogramming
    Rao, Radhika Arasala
    Dhele, Narendra
    Cheemadan, Sabna
    Ketkar, Alhad
    Jayandharan, Giridhara R.
    Palakodeti, Dasaradhi
    Rampalli, Shravanti
    SCIENTIFIC REPORTS, 2015, 5
  • [43] Inhibition of EZH2 Promotes Human Embryonic Stem Cell Differentiation into Mesoderm by Reducing H3K27me3
    Yu, Yongxin
    Deng, Peng
    Yu, Bo
    Szymanski, John M.
    Aghaloo, Tara
    Hong, Christine
    Wang, Cun-Yu
    STEM CELL REPORTS, 2017, 9 (03): : 752 - 761
  • [44] Evaluation of Histone 3 Lysine 27 Trimethylation (H3K27me3) and Enhancer of Zest 2 (EZH2) in Pediatric Glial and Glioneuronal Tumors Shows Decreased H3K27me3 in H3F3A K27M Mutant Glioblastomas
    Venneti, Sriram
    Garimella, Mihir T.
    Sullivan, Lisa M.
    Martinez, Daniel
    Huse, Jason T.
    Heguy, Adriana
    Santi, Mariarita
    Thompson, Craig B.
    Judkins, Alexander R.
    BRAIN PATHOLOGY, 2013, 23 (05) : 558 - 564
  • [45] The role of EZH2 and H3K27me3 epigenetic signature in modulating T-cell polarization in atherosclerosis
    Bonfiglio, C. A.
    Lacy, M.
    Janjic, A.
    Kucukgoze, I. Avcilar
    Nitz, K.
    Wu, Y.
    Wange, L. E.
    Santovito, D.
    Bosmans, L. A.
    Imhof, A.
    Enard, W.
    Weber, C.
    De Winther, M.
    Lutgens, E.
    Atzler, D.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [46] The EZH2–PRC2–H3K27me3 axis governs the endometrial cell cycle and differentiation for blastocyst invasion
    Yamato Fukui
    Yasushi Hirota
    Shizu Aikawa
    Akihiko Sakashita
    Ryoko Shimizu-Hirota
    Norihiko Takeda
    Chihiro Ishizawa
    Rei Iida
    Tetsuaki Kaku
    Tomoyuki Hirata
    Takehiro Hiraoka
    Shun Akaeda
    Mitsunori Matsuo
    Yutaka Osuga
    Cell Death & Disease, 14
  • [47] MELK aggravates lung adenocarcinoma by regulating EZH2 ubiquitination and H3K27me3 histone methylation of LATS2
    Yu, Hui
    Xu, Xianrong
    Zhu, Lirong
    Chen, Shengjie
    He, Jincheng
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (08)
  • [48] Altered expression of epigenetic modifiers EZH2, H3K27me3, and DNA methyltransferases in meningiomas - prognostic biomarkers for routine practice
    Samal, Swagatika
    Patnaik, Ashis
    Sahu, Fakir Mohan
    Purkait, Suvendu
    FOLIA NEUROPATHOLOGICA, 2020, 58 (02) : 133 - 142
  • [49] Synchronous T-lymphoblastic lymphoma and neuroblastoma in a 3-yr-old with novel germline SMARCA4 and EZH2 variants
    Tibout, Pauline
    Livingston, Joel
    Kanwar, Nisha
    Yuki, Kyoko E.
    Shlien, Adam
    Ngan, Bo
    Irwin, Meredith S.
    Morgenstern, Daniel A.
    Hitzler, Johann
    Villani, Anita
    Cohen-Gogo, Sarah
    COLD SPRING HARBOR MOLECULAR CASE STUDIES, 2023, 9 (04):
  • [50] EZH2-mediated H3K27me3 inhibits ACE2 expression
    Li, Yuanyuan
    Li, Honggang
    Zhou, Liquan
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 526 (04) : 947 - 952
12345